St. Louis, MO, United States of America

Matthew Ellis

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.1

ph-index = 3

Forward Citations = 13(Granted Patents)


Location History:

  • St. Louis, MO (US) (2015 - 2017)
  • Houston, TX (US) (2018)

Company Filing History:


Years Active: 2015-2018

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Matthew Ellis

Introduction

Matthew Ellis is a prominent inventor based in St. Louis, MO (US). He has made significant contributions to the field of breast cancer research, holding a total of 4 patents. His work focuses on developing methods for predicting breast cancer outcomes and improving treatment options for patients.

Latest Patents

One of his latest patents is titled "Copy number aberration driven endocrine response gene signature." This patent discloses methods for predicting the likelihood of long-term survival without recurrence of breast cancer in subjects with estrogen receptor-positive (ER+) breast cancer treated with adjuvant endocrine monotherapy. The methods involve performing a gene expression profile of a breast tissue sample and calculating a risk score to classify subjects into sensitive, indeterminate, or resistant groups. This classification helps predict longer relapse-free survival for patients.

Another significant patent is "Method of classifying a breast cancer intrinsic subtype." This invention provides methods for classifying and evaluating the prognosis of breast cancer patients. It includes a prediction model based on the gene expression profile of intrinsic genes, which can accurately predict the intrinsic subtype of a subject diagnosed with breast cancer. The methods also guide treatment options for patients based on their predicted outcomes.

Career Highlights

Matthew Ellis has worked with esteemed institutions such as Washington University and the University of Utah Research Foundation. His research has significantly advanced the understanding of breast cancer and its treatment.

Collaborations

He has collaborated with notable colleagues, including Charles M. Perou and Philip Seth Bernard, contributing to the collective knowledge in the field of cancer research.

Conclusion

Matthew Ellis's innovative work in breast cancer research has led to valuable patents that enhance the understanding and treatment of the disease. His contributions continue to impact the lives of many patients facing breast cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…